Search

Latest Research: FDG-PET/CT as a non-invasive biomarker for R assessing adequacy of treatment and predicting relapse patients treated for Pulmonary Tuberculosis

2 Sep 2019 - 15:45

Professor Mark Hatherill has co-authored a journal article titled: "FDG-PET/CT as a non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis" appearing in the Journal of Nuclear Medicine.

To view abstract click here.